4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-008125
Chief Financial Officer sold 1,781 shares at $14.21 ($25,308)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal Chief Financial Officer | 2020-02-06 | Sale | −1,781 | $14.21 | $25,308 | 72,282 | D: show line 1 in the form |
| Open-market sales · 1,781 sh · avg $14.21 · $25,308 | |||||||
Loading xslF345X03/doc4.xml…